Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Evidence-based guidelines on the therapeutic use of repetitive transcranial magnetic stimulation (rTMS).
Fingolimod protects against neonatal white matter damage and long-term cognitive deficits caused by hyperoxia.
Continuous long-term immunomodulatory therapy in relapsing multiple sclerosis: results from the 15-year analysis of the US prospective open-label study of glatiramer acetate.
Improvement of interferon-beta related skin reactions after diluent halving: first experience of five patients.
A technical approach to dissecting and assessing cadaveric veins pertinent to chronic cerebrospinal venous insufficiency in multiple sclerosis.
Tumefactive multiple sclerosis lesions under fingolimod treatment.
Use of a Standardized MxA Protein Measurement-Based Assay for Validation of Assays for the Assessment of Neutralizing Antibodies Against Interferon-β
Remyelinating Oligodendrocyte Precursor Cell miRNAs from the Sfmbt2 Cluster Promote Cell Cycle Arrest and Differentiation.
Elevated plasma high-mobility group box 1 protein is a potential marker for neuromyelitis optica.
Using Twitter to investigate opinions about multiple sclerosis treatments: a descriptive, exploratory study.
Bee Venom Acupuncture Alleviates Experimental Autoimmune Encephalomyelitis by Upregulating Regulatory T Cells and Suppressing Th1 and Th17 Responses.
HSV1 and 2 Detection in the CSF of Multiple Sclerosis Patients by Real-time PCR.
Human glial chimeric mice reveal astrocytic dependence of JC virus infection.
Clinical correlations of motor and somatosensory evoked potentials in neuromyelitis optica.
The autoimmune disease-associated transcription factors EOMES and TBX21 are dysregulated in multiple sclerosis and define a molecular subtype of disease.
New Clues to Link Between MS Drug Tysabri and Rare Brain Disease
Simple MRI Metrics Contribute to Optimal Care of the Patient with Multiple Sclerosis.
Severe Bilateral Heterotopic Ossification in a Patient With Multiple Sclerosis.
Development of a cell-based assay for the detection of anti-aquaporin 1 antibodies in neuromyelitis optica spectrum disorders.
Deep brain stimulation of the ventral intermediate nucleus of the thalamus for tremor in patients with multiple sclerosis.
Autophagy in immunity: Implications in etiology of autoimmune/autoinflammatory diseases.
Misoprostol as a Therapeutic Option for Trigeminal Neuralgia in Patients with Multiple Sclerosis.
The role of IL-2 in the activation and expansion of regulatory T-cells and the development of experimental autoimmune encephalomyelitis.
Microcystic macular oedema, thickness of the inner nuclear layer of the retina, and disease characteristics in multiple sclerosis: a retrospective study.
The pharmacokinetics of glatiramer acetate for multiple sclerosis treatment.
Pages
« first
‹ previous
…
288
289
290
291
292
293
294
295
296
…
next ›
last »